Virios Therapeutics's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Virios Therapeutics (NASDAQ:VIRI) is expected to release its quarterly earnings report on Monday, 2023-11-13, with an estimated EPS of $-0.09. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has been sensitive to earnings performance, with a 20.31% drop after missing EPS last quarter. Shares are currently trading at $0.75, up 190.5% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.
November 10, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Virios Therapeutics is set to report earnings with an anticipated EPS of $-0.09. A history of stock sensitivity to earnings performance suggests potential volatility post-announcement. Long-term bullish trend with shares up 190.5% over 52 weeks.
The short-term impact on VIRI's stock price will likely depend on whether the company meets or exceeds the estimated EPS and provides positive guidance. Given the stock's historical sensitivity to earnings reports, a significant move in either direction could occur. However, the current bullish trend may temper the impact of a negative earnings surprise.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100